Academic literature on the topic '4CMenB'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '4CMenB.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "4CMenB"
Gönüllü, Erdem, Burcu Topçu, Naci Öner, Ahmet Soysal, and Metin Karaböcüoğlu. "Fever-Associated Supraventricular Tachycardia after 4CMenB Vaccination in an Infant." Case Reports in Pediatrics 2019 (September 22, 2019): 1–3. http://dx.doi.org/10.1155/2019/4591964.
Full textKent, Alison, Kazim Beebeejaun, Serena Braccio, Seilesh Kadambari, Paul Clarke, Paul T. Heath, and Shamez Ladhani. "Safety of meningococcal group B vaccination in hospitalised premature infants." Archives of Disease in Childhood - Fetal and Neonatal Edition 104, no. 2 (April 10, 2018): F171—F175. http://dx.doi.org/10.1136/archdischild-2017-314152.
Full textMarshall, Helen S., Prabha H. Andraweera, James Ward, John Kaldor, Ross Andrews, Kristine Macartney, Peter Richmond, et al. "An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol." Vaccines 10, no. 2 (February 16, 2022): 309. http://dx.doi.org/10.3390/vaccines10020309.
Full textYamashiro, Hirotaka, Nora Cutcliffe, Simon Dobson, David Fisman, and Ronald Gold. "The Role of Pediatricians as Key Stakeholders in Influencing Immunization Policy Decisions for the Introduction of Meningitis B Vaccine in Canada: The Ontario Perspective." Canadian Journal of Infectious Diseases and Medical Microbiology 26, no. 4 (2015): 183–90. http://dx.doi.org/10.1155/2015/963940.
Full textKimura, Alan, Daniela Toneatto, Annett Kleinschmidt, Huajun Wang, and Peter Dull. "Immunogenicity and Safety of a Multicomponent Meningococcal Serogroup B Vaccine and a Quadrivalent Meningococcal CRM197Conjugate Vaccine against Serogroups A, C, W-135, and Y in Adults Who Are at Increased Risk for Occupational Exposure to Meningococcal Isolates." Clinical and Vaccine Immunology 18, no. 3 (December 22, 2010): 483–86. http://dx.doi.org/10.1128/cvi.00304-10.
Full textIsitt, Catherine, Catherine A. Cosgrove, Mary Elizabeth Ramsay, and Shamez N. Ladhani. "Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience." Archives of Disease in Childhood 105, no. 8 (February 6, 2020): 784–90. http://dx.doi.org/10.1136/archdischild-2019-318047.
Full textLucidarme, Jay, Stefanie Gilchrist, Lynne S. Newbold, Stephen J. Gray, Edward B. Kaczmarski, Lynne Richardson, Julia S. Bennett, Martin C. J. Maiden, Jamie Findlow, and Ray Borrow. "Genetic Distribution of Noncapsular Meningococcal Group B Vaccine Antigens in Neisseria lactamica." Clinical and Vaccine Immunology 20, no. 9 (June 26, 2013): 1360–69. http://dx.doi.org/10.1128/cvi.00090-13.
Full textNolan, Terry, Hartley Garfield, Anil Gupta, Murdo Ferguson, Helen Marshall, Diego D’Agostino, and Daniela Toneatto. "Persistence of Bactericidal Activity at 4 Years After 2 Primary Doses of a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Adolescents and Young Adults." Open Forum Infectious Diseases 4, suppl_1 (2017): S322. http://dx.doi.org/10.1093/ofid/ofx163.757.
Full textAzzari, Chiara, Maria Moriondo, Francesco Nieddu, Valentina Guarnieri, Lorenzo Lodi, Clementina Canessa, Giuseppe Indolfi, et al. "Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018)." Vaccines 8, no. 3 (August 22, 2020): 469. http://dx.doi.org/10.3390/vaccines8030469.
Full textSoler-Garcia, Aleix, Mariona Fernández de Sevilla, Raquel Abad, Cristina Esteva, Laia Alsina, Julio Vázquez, Carmen Muñoz-Almagro, and Antoni Noguera-Julian. "Meningococcal Serogroup B Disease in Vaccinated Children." Journal of the Pediatric Infectious Diseases Society 9, no. 4 (October 21, 2019): 454–59. http://dx.doi.org/10.1093/jpids/piz071.
Full textDissertations / Theses on the topic "4CMenB"
Viviani, Viola <1992>. "Dissection of the protective response elicited by the DOMV component of the 4CMenB vaccine." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2021. http://amsdottorato.unibo.it/9779/1/Viviani_Viola_tesi.pdf.
Full textJördens, Markus Sebastian [Verfasser], and Ulrich [Gutachter] Vogel. "Einfluss des Komplementsystems und der neuartigen Meningokokken-Vakzine 4CMenB auf cnl-Meningokokken / Markus Sebastian Jördens ; Gutachter: Ulrich Vogel." Würzburg : Universität Würzburg, 2017. http://d-nb.info/1130587975/34.
Full textNDONI, ENEA. "Characterization of the immune response and cross protection activity elicited by the Neisserial Heparin Binding Antigen (NHBA), a component of the 4CMenB vaccine." Doctoral thesis, Università di Siena, 2017. http://hdl.handle.net/11365/1011542.
Full textJördens, Markus Sebastian. "Einfluss des Komplementsystems und der neuartigen Meningokokken-Vakzine 4CMenB auf cnl-Meningokokken." Doctoral thesis, 2016. https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-147071.
Full textIn this study we typed Vaccine-relevant outer membrane antigens of cnl-meningococci. Furthermore we analysed the interactions of cnl-meningococci with the complement System, especially with the main Regulators factor H and C4bp. The data should help to estimate the impact of 4CMenB, a vaccine against meningococci of serogroup B which was introduced to the german market in 2013, on cnl-meningococci. In addition we examined the interactions of the complemet system with cnl-meningocicci, which are supposed to be apathogen and maybe beneficial for the development of natural immunity. A selection of cnl-meningococci which represent the genetical variability of that bacteria Population was typed for outer membrane Proteins by PCR (porA, porB, fetA, opc, fHbp, nhba, nadA) or western-blot (opc). A close assotiation of allels to clonal complexes could be shown. It is likely that cnl-meningococci are not detected by Bexsero-induced antibodies as their antigen pattern differs from the vaccine Antigens. The only Antigen which ould be detected is NhbA. Factor H and C4bp-binding to cnl-meningococci was examined using flow cytometry Analysis. The binding of fH or C4bp to cnl-meningococci was significantly lower as to fH- or C4cb-binding controll strains. Furthermore serum resistance of cnl-meningococci in vitro is low, which is also an indicator for weak binding of Regulators of the complement System. This finding underlines the apathogen nature of cnl-meningococci. It also indicates the problem of serum bactericidity tests to assess the impact of antibodies induced by protein based vaccines
McMillan, Mark. "Impact of meningococcal vaccines on carriage and disease." Thesis, 2021. https://hdl.handle.net/2440/132672.
Full textThesis (Ph.D.) -- University of Adelaide, Adelaide Medical School, 2021
花麒昌. "整合消費者行為模式與服務代理人之網路購物輔助系統." Thesis, 2004. http://ndltd.ncl.edu.tw/handle/4cmez6.
Full text國立清華大學
工業工程與工程管理學系
92
Due to the rapidly growing internet commercial activities, many businesses have been making their own e-Business websites. They might hope these websites could serve their potential consumers with sufficient products and service information. Unfortunately, finding information from separate websites is time-consuming for consumers, not to mention the disturbance of integrating all the information and evaluating them. Customers often lose their patience and desire of purchasing products in this process, which frustrated them. In the domain of e-Business, researchers have suggested that businesses should have “virtual agents” serve in the shopping websites for customers. This is because the agent could help customers in gathering substantial product information, searching available products, giving choice suggestions, assisting purchasing processes, and providing after purchase services. The agent is expected to increase consumers’ desire and satisfaction when they are purchasing on Internet. In this study, a virtual agent system was established based on the consumers’ need in searching, selecting and evaluating the products in the consumer behavior model. Mental load and time for purchasing were two chosen indicators, and both subjective and objective measures were used to evaluate the effect. The functions of agent include supplying the consumers with integrated product information, purchasing suggestions according to consumers’ budget and preference, buying process assistance, and after purchase service. More satisfied performance with indicators is expected when using the agent. The result certifies this hypothesis. It is concluded that virtual agent in the study is indeed helpful in the purchasing process and is of high potential for e-business.
Book chapters on the topic "4CMenB"
Boccadifuoco, Giuseppe, Brunella Brunelli, Elena Mori, Mauro Agnusdei, Claudia Gianfaldoni, and Marzia Monica Giuliani. "Meningococcal Antigen Typing System (MATS): A Tool to Estimate Global Coverage for 4CMenB, a Multicomponent Meningococcal B Vaccine." In Methods in Molecular Biology, 205–15. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9202-7_14.
Full textConference papers on the topic "4CMenB"
Franco, Nathércia, Aline Azevedo, and Ivano Filippis. "Distribuição dos antígenos de superfície incluídos na vacina meningocócica 4CMenB em amostras brasileiras no período de 2010 a 2015." In VI Seminário Anual Científico e Tecnológico. Instituto de Tecnologia em Imunobiológicos, 2018. http://dx.doi.org/10.35259/isi.sact.2018_27108.
Full textChannon-Wells, Samuel, Emily Tough, Neda So, Daniel O’Connor, and Matthew Snape. "269 Differentiating vaccine reactions from invasive bacterial infections in infants presenting to the emergency department in the 4CMenB era: a retrospective descriptive comparison." In Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference, Liverpool, 28–30 June 2022. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2022. http://dx.doi.org/10.1136/archdischild-2022-rcpch.9.
Full text